Loading profile…
Riskpilot
← Back to search
Sign in
Get full access
KL
Kai Lotherington
Chief Executive Officer, LYNX UNLIMITED AS
NO
4 active roles
Watchlist
Share
Overview
Companies & roles
Network
Active roles
4
directorships & management
Past roles
2
historical positions
Dissolved companies
0
in directorship history
Career timeline
2024 – now
Legal Owner, NYKODE THERAPEUTICS ASA
2024 – now
Legal Owner, CIRCIO HOLDING ASA
2022 – now
Legal Owner, LYTIX BIOPHARMA ASA
2020 – 2020
Board of Directors, CHR. HOLTERMANN AS
2013 – 2022
Board of Directors, HOLTERMANN SOLUTIONS AS
1996 – now
Chief Executive Officer, LYNX UNLIMITED AS
Personal details
Nationality
NO
Active roles
4 positions
Company
Role
Period
Ownership
Status
LYNX UNLIMITED AS
CVR 967492515
Management
Chief Executive Officer
Since 1996
—
Active
LYTIX BIOPHARMA ASA
CVR 985889635
Owner
Legal Owner
Since 2022
0.1%
Active
NYKODE THERAPEUTICS ASA
CVR 990646066
Owner
Legal Owner
Since 2024
0.0%
Active
CIRCIO HOLDING ASA
CVR 996162095
Owner
Legal Owner
Since 2024
0.0%
Active
Historical roles
2 positions
Company
Role
Period
Ownership
Status
CHR. HOLTERMANN AS
CVR 922828407
Board
Board of Directors
2020 – 2020
—
Active
HOLTERMANN SOLUTIONS AS
CVR 812385062
Board
Board of Directors
2013 – 2022
—
Active
Co-directors & shared companies
Person
Role
Shared companies
Profile
TM
Tatjana Maria Lotherington
Deputy Member
1
company
View profile
ØR
Øystein Rekdal
Chief Executive Officer
1
company
View profile
KH
Kjetil Hestdal
Board of Directors
1
company
View profile
JH
Julie Helene Madeleine Dehaene
Board of Directors
1
company
View profile
HM
Helena Marie-Louise Fjällskog
Board of Directors
1
company
View profile
Company network
Active roles
Kai Lotherington
LYNX UNLIMITED AS
Chief Executive Officer
LYTIX BIOPHARMA ASA
Legal Owner
NYKODE THERAPEUTICS ASA
Legal Owner
CIRCIO HOLDING ASA
Legal Owner